Janssen Strategy News Today

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2024 Earnings Call Transcript September 14, 2023 ImmunoPrecise Antibodies Ltd. misses on earnings expectations. Reported EPS is $0.11 EPS, expectations were $0.17. Operator: Good morning, ladies and gentlemen. Thank you for joining us today for IPA’s Earnings Call covering the First Quarter of Fiscal Year 2024. I am Julianne, and […]

05.09.2023 - IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an advanced biotherapeutic research and technology company, is pleased to announce that further to its news release dated August 9, 2023, it has appointed, in its search for ... Seite 1